RankAlpha logo
Back to Rankings

OKUR

OnKure TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
OKUR vs peer average
22/100
OKUR vs. peer average (F vs. C)
Grade spread
A 1 · B 1 · C 3 · D 1 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

IPHA is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $171.03M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerIPHAInnate
OKUR
OnKure Therapeutics
IPHA
Innate
Grade
F
F
Momentum
33
18
Value
41
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs IPHA

OKUR / IPHA
Grade Position
Below peers
OKUR vs. peer average (F vs. C)
22/100
Momentum
33
OKUR
Value
41
OKUR
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs OKUR
1
IPHA
Innate Pharma SA ADR
F
20/100
Even
2
ARTV
Artiva Biotherapeutics Inc Common
D
40/100
-1
3
ABOS
Acumen Pharmaceuticals Inc Common
A
100/100
-4
4
TNYA
Tenaya Therapeutics Inc Common
B
80/100
-3
5
NRXP
NRX Pharmaceuticals Inc Common
C
60/100
-2
IPHA is the first peer returned for this comparison set.